Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Parker C. Dryja"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-8 (2019)
Abstract Expression of PDL1 on the surface of tumor cells can blunt the efficacy of many cancer immunotherapies. For example, our lab has previously shown that tumors derived from malignant cells incapable of expressing PDL1 are highly susceptible to
Externí odkaz:
https://doaj.org/article/0cda94d2b59b42d1ade2c0d8bb034b59
Publikováno v:
J Immunother
Polyamines are known to play a significant role in cancer progression and treatment using difluoromethylornithine (DFMO), an inhibitor of polyamine biosynthesis, has shown some clinical promise. It is interesting to note that, while DFMO is directly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3ad99962269bb52a02b027427ae2767
https://europepmc.org/articles/PMC8416699/
https://europepmc.org/articles/PMC8416699/
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-8 (2019)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Expression of PDL1 on the surface of tumor cells can blunt the efficacy of many cancer immunotherapies. For example, our lab has previously shown that tumors derived from malignant cells incapable of expressing PDL1 are highly susceptible to immunoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92994509f2cad40acc3ecc37a3814719
http://link.springer.com/article/10.1186/s40425-018-0496-6
http://link.springer.com/article/10.1186/s40425-018-0496-6